P6267Novel direct effects of SGLT2 inhibitor, Canagliflozin, on myocardial redox state in humans (2019)
Attributed to:
The predictive value of molecular and imaging markers for future cardiovascular events and outcomes
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehz746.0866
Publication URI: http://dx.doi.org/10.1093/eurheartj/ehz746.0866
Type: Journal Article/Review
Parent Publication: European Heart Journal
Issue: Supplement_1